CRYO-VACC THE ANSWER TO SAFE TRANSPORTATION OF THE COVID-19 VACCINE
Renergen has found a great solution to a challenge. As many of us now know, the COVID-19 vaccine requires strict and consistent temperature-controlled packaging during transportation and the Cyro-Vacc is here to help.
Cyro-Vacc is essentially an aluminium case that is powered by Helium. It’s able to safely transport a minimum of 100 doses and has an adjustable temperature of –70 degrees Celsius to -150 degrees Celsius.
Biologics and vaccines can therefore be transported for up to 30 days, without the temperature being affected. It also protects the COVID-19 vaccines from light exposure.
“With the Renergen Cryo-Vacc, transportation of these vaccines can be achieved in a cost-effective manner, given the relatively small size and weight. Depending on where and how the helium is sourced, the operating cost of the case should be under US$3 per month for each dose,” Renergen said.
CHALLENGES IT WILL SOLVE
South Africa has secured 20-million Pfizer vaccines, however, there are concerns regarding the maintenance of the COVID-19 vaccine’s ultra-cold storage temperature and ensuring it doesn’t change during transportation.
Renergen said the Cryo-Vacc can solve the following challenges;
- Pharmaceutical companies have unique complex supply chain requirements. Typically the delivery of biologics and vaccines require a number of handoffs from the manufacturing site, storage depots, and various modes of transport, to reach the ultimate destination;
- Provides control over the integrity of the doses, with regards to temperature monitoring is difficult to manage and control and even more so in remote areas;
- GPS-enabled temperature sensors, to track location and monitor temperature remotely; and
- More and more clinical trials will require the delivery of temperature-sensitive drugs in the future. The Renergen Cryo-Vacc, can be used to transport not only the COVID-19 vaccine, but other vaccines and biologics as well.
